U.S. markets open in 3 hours 41 minutes
  • S&P Futures

    3,678.25
    +24.00 (+0.66%)
     
  • Dow Futures

    29,442.00
    +157.00 (+0.54%)
     
  • Nasdaq Futures

    11,289.75
    +61.50 (+0.55%)
     
  • Russell 2000 Futures

    1,697.20
    +15.10 (+0.90%)
     
  • Crude Oil

    82.09
    +0.86 (+1.06%)
     
  • Gold

    1,677.30
    +8.70 (+0.52%)
     
  • Silver

    19.08
    +0.37 (+1.99%)
     
  • EUR/USD

    0.9810
    -0.0010 (-0.10%)
     
  • 10-Yr Bond

    3.7470
    0.0000 (0.00%)
     
  • Vix

    31.06
    +0.88 (+2.92%)
     
  • GBP/USD

    1.1170
    +0.0047 (+0.42%)
     
  • USD/JPY

    144.3250
    -0.1180 (-0.08%)
     
  • BTC-USD

    19,525.93
    +48.40 (+0.25%)
     
  • CMC Crypto 200

    446.46
    +0.48 (+0.11%)
     
  • FTSE 100

    6,927.13
    +45.54 (+0.66%)
     
  • Nikkei 225

    25,937.21
    -484.84 (-1.83%)
     

NanoViricides, Inc. Investors Who Purchased NNVC Securities After January 2020 And Suffered Losses Greater Than $50,000 Encouraged To Contact Kehoe Law Firm, P.C.

·1 min read

PHILADELPHIA, July 16, 2020 (GLOBE NEWSWIRE) -- Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of NanoViricides, Inc. (“NanoViricides” or the “Company”) (NYSE: NNVC) to determine whether the Company engaged in securities fraud or other unlawful business practices.

The securities investigation concerns whether NanoViricides provided false or misleading information to investors about its activities related to drug development, including a potential treatment for COVID-19.

NanoViricides investors who purchased, or otherwise acquired, the Company’s securities after January 2020 and suffered losses greater than $50,000 are encouraged to complete Kehoe Law Firm’s Securities Class Action Questionnaire or contact Kevin Cauley, Director, Business Development, (215) 792-6676, Ext. 802, securities@kehoelawfirm.com, info@kehoelawfirm.com, to discuss the securities investigation or potential legal claims.

Kehoe Law Firm, P.C., with offices in New York and Philadelphia, is a multidisciplinary, plaintiff–side law firm dedicated to protecting investors from securities fraud, breaches of fiduciary duties, and corporate misconduct. Combined, the partners at Kehoe Law Firm have served as Lead Counsel or Co-Lead Counsel in cases that have recovered more than $10 billion on behalf of institutional and individual investors.

This press release may constitute attorney advertising.